A phase II study of GW572016 [lapatinib] and tamoxifen in patients with metastatic breast cancer resistant to single agent tamoxifen
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Lapatinib (Primary) ; Tamoxifen
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Aug 2006 New trial record.